Remote Ischemic Conditioning for Spinal Cord Injuries
This study is looking at a treatment called Remote Ischemic Conditioning (RIC) for people with spinal cord injuries (SCI). RIC involves briefly restricting blood flow to an arm or leg using a blood pressure cuff. Researchers want to see if RIC, done at home, can improve heart and metabolic health. They are comparing three different ways of doing RIC: high-dose using a standard blood pressure cuff, high-dose using an automated blood flow restriction cuff, and low-dose using a standard blood pressure cuff. The main goal is to see if these methods are practical for people with SCI to do at home and to gather information on how they affect heart health. You can join if you are 18 or older, have an SCI, live at home, and are not currently very active.
- Study design
- This is an interventional study with 24 participants. It compares three different ways of applying Remote Ischemic Conditioning (RIC).
- What's involved
- Participants will apply Remote Ischemic Conditioning (RIC) at home 5 days a week for 6 weeks. Measurements of arm artery size and arterial stiffness will be taken at the beginning and up to 2 weeks after the intervention.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed up to 2 weeks after the 6-week intervention period.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Remote Ischemic Conditioning for PwSCI
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Kerri A Morgan, PhD · PRINCIPAL_INVESTIGATOR · Washington University School of Medicine - Program in Occupational Therapy
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Brachial artery diameter change (cm)Baseline and up to 2 weeks post intervention
Participants will undergo a Brachial Artery Reactivity Test (BART) via upper arm doppler ultrasound. The test will measure flow-mediated dilation and endothelium independent dilation of the brachial artery using a high-resolution transducer on the Vivid E95, E9, Vivid IQ (portable) or Vivid I (portable) systems. Brachial artery flow-mediated vasodilation correlates with measures of coronary artery endothelial function and can predict future adverse coronary events. Results will be reported as brachial artery diameter change between baseline and 30 seconds into test, unit of measure is cm.
- Arterial stiffness - Pulse wave velocity (PWV)Baseline and up to 2 weeks post intervention
This test is a non-invasive cardiovascular assessment that measures arterial stiffness. Arterial stiffness will be obtained by measuring carotid-femoral pulse wave velocity using the SphygmoCor XCEL system.